| Dr Angelo Pulgiano, MD | |
|
12391 S 4000 W, Riverton, UT 84096-7012 | |
| (801) 302-1700 | |
| (801) 302-1714 |
| Full Name | Dr Angelo Pulgiano |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 22 Years |
| Location | 12391 S 4000 W, Riverton, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952322836 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 25MA07930400 (New Jersey) | Secondary |
| 207R00000X | Internal Medicine | 7967325-1205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Symbii Home Health South | West valley city, UT | Home health agency |
| Riverton Hospital | Riverton, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Granger Medical Clinic Pc | 3476465691 | 115 |
| Granger Medical Specialists Llc | 4587074356 | 157 |
News Archive
A paper published in the current issue of P&P? tests the widely accepted assumption in drug trials: neither evaluators nor patients know whether the patient is getting drug or placebo (double blindness).
Researchers from Scynexis Inc. of Research Triangle Park, N.C., and Anacor Pharmaceuticals in Palo Alto, Calif., sponsored by the Drugs for Neglected Diseases initiative, on Tuesday reported in the journal PLoS Neglected Tropical Diseases that a new experimental drug kills the parasite that causes African sleeping sickness in mice and will enter human clinical trials this year, ScienceNOW reports.
Cannabis Science, Inc., a pioneering U.S. biotech company developing pharmaceutical cannabis products, has issued a statement regarding a Canadian study on marijuana and intractable post-traumatic or post-surgery neuropathic pain that did not respond to conventional treatment.
Researchers from Boston University School of Medicine, along with clinicians from Boston Medical Center, have found gastroenterologist knowledge of the appropriate immunizations to recommend to the inflammatory bowel disease patient is limited.
New research shows women who don't receive a clot-busting drug after a stroke fare worse than men who are not treated. The study is published in the March 2, 2010, print issue of Neurology®, the medical journal of the American Academy of Neurology.
› Verified 5 days ago
| Entity Name | Granger Medical Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184657041 PECOS PAC ID: 3476465691 Enrollment ID: O20031105000159 |
News Archive
A paper published in the current issue of P&P? tests the widely accepted assumption in drug trials: neither evaluators nor patients know whether the patient is getting drug or placebo (double blindness).
Researchers from Scynexis Inc. of Research Triangle Park, N.C., and Anacor Pharmaceuticals in Palo Alto, Calif., sponsored by the Drugs for Neglected Diseases initiative, on Tuesday reported in the journal PLoS Neglected Tropical Diseases that a new experimental drug kills the parasite that causes African sleeping sickness in mice and will enter human clinical trials this year, ScienceNOW reports.
Cannabis Science, Inc., a pioneering U.S. biotech company developing pharmaceutical cannabis products, has issued a statement regarding a Canadian study on marijuana and intractable post-traumatic or post-surgery neuropathic pain that did not respond to conventional treatment.
Researchers from Boston University School of Medicine, along with clinicians from Boston Medical Center, have found gastroenterologist knowledge of the appropriate immunizations to recommend to the inflammatory bowel disease patient is limited.
New research shows women who don't receive a clot-busting drug after a stroke fare worse than men who are not treated. The study is published in the March 2, 2010, print issue of Neurology®, the medical journal of the American Academy of Neurology.
› Verified 5 days ago
| Entity Name | University Of Utah Community Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598169203 PECOS PAC ID: 9739403569 Enrollment ID: O20150126002118 |
News Archive
A paper published in the current issue of P&P? tests the widely accepted assumption in drug trials: neither evaluators nor patients know whether the patient is getting drug or placebo (double blindness).
Researchers from Scynexis Inc. of Research Triangle Park, N.C., and Anacor Pharmaceuticals in Palo Alto, Calif., sponsored by the Drugs for Neglected Diseases initiative, on Tuesday reported in the journal PLoS Neglected Tropical Diseases that a new experimental drug kills the parasite that causes African sleeping sickness in mice and will enter human clinical trials this year, ScienceNOW reports.
Cannabis Science, Inc., a pioneering U.S. biotech company developing pharmaceutical cannabis products, has issued a statement regarding a Canadian study on marijuana and intractable post-traumatic or post-surgery neuropathic pain that did not respond to conventional treatment.
Researchers from Boston University School of Medicine, along with clinicians from Boston Medical Center, have found gastroenterologist knowledge of the appropriate immunizations to recommend to the inflammatory bowel disease patient is limited.
New research shows women who don't receive a clot-busting drug after a stroke fare worse than men who are not treated. The study is published in the March 2, 2010, print issue of Neurology®, the medical journal of the American Academy of Neurology.
› Verified 5 days ago
| Entity Name | Granger Medical Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376159368 PECOS PAC ID: 4587074356 Enrollment ID: O20201105002207 |
News Archive
A paper published in the current issue of P&P? tests the widely accepted assumption in drug trials: neither evaluators nor patients know whether the patient is getting drug or placebo (double blindness).
Researchers from Scynexis Inc. of Research Triangle Park, N.C., and Anacor Pharmaceuticals in Palo Alto, Calif., sponsored by the Drugs for Neglected Diseases initiative, on Tuesday reported in the journal PLoS Neglected Tropical Diseases that a new experimental drug kills the parasite that causes African sleeping sickness in mice and will enter human clinical trials this year, ScienceNOW reports.
Cannabis Science, Inc., a pioneering U.S. biotech company developing pharmaceutical cannabis products, has issued a statement regarding a Canadian study on marijuana and intractable post-traumatic or post-surgery neuropathic pain that did not respond to conventional treatment.
Researchers from Boston University School of Medicine, along with clinicians from Boston Medical Center, have found gastroenterologist knowledge of the appropriate immunizations to recommend to the inflammatory bowel disease patient is limited.
New research shows women who don't receive a clot-busting drug after a stroke fare worse than men who are not treated. The study is published in the March 2, 2010, print issue of Neurology®, the medical journal of the American Academy of Neurology.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Angelo Pulgiano, MD 7181 S Campus View Dr Ste 200, West Jordan, UT 84084-4312 Ph: (801) 965-3505 | Dr Angelo Pulgiano, MD 12391 S 4000 W, Riverton, UT 84096-7012 Ph: (801) 302-1700 |
News Archive
A paper published in the current issue of P&P? tests the widely accepted assumption in drug trials: neither evaluators nor patients know whether the patient is getting drug or placebo (double blindness).
Researchers from Scynexis Inc. of Research Triangle Park, N.C., and Anacor Pharmaceuticals in Palo Alto, Calif., sponsored by the Drugs for Neglected Diseases initiative, on Tuesday reported in the journal PLoS Neglected Tropical Diseases that a new experimental drug kills the parasite that causes African sleeping sickness in mice and will enter human clinical trials this year, ScienceNOW reports.
Cannabis Science, Inc., a pioneering U.S. biotech company developing pharmaceutical cannabis products, has issued a statement regarding a Canadian study on marijuana and intractable post-traumatic or post-surgery neuropathic pain that did not respond to conventional treatment.
Researchers from Boston University School of Medicine, along with clinicians from Boston Medical Center, have found gastroenterologist knowledge of the appropriate immunizations to recommend to the inflammatory bowel disease patient is limited.
New research shows women who don't receive a clot-busting drug after a stroke fare worse than men who are not treated. The study is published in the March 2, 2010, print issue of Neurology®, the medical journal of the American Academy of Neurology.
› Verified 5 days ago
Richard Mccurry Patten, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3741 W. 12600 S., Riverton Hospital, Riverton, UT 84065 Phone: 801-285-2200 Fax: 801-285-2211 | |
Dr. Garrett Bird, MD, CM Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4063 W 12600 S # Sabs, Riverton, UT 84096 Phone: 801-935-8180 Fax: 801-931-2307 | |
Dr. Marcellus Saka Assiago, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 12523 S Creek Meadow Rd Ste 111, Riverton, UT 84065 Phone: 801-288-2634 Fax: 801-288-1186 | |
Dr. Ying Ning, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 3723 W 12600 S Bldg 2, Ste 350, Riverton, UT 84065 Phone: 801-285-4750 | |
Brett W Doxey, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3741 W 12600 S, #470, Riverton, UT 84065 Phone: 801-727-4280 Fax: 801-254-8331 | |
Dr. Eric Allen, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3723 W 12600 S Ste 270, Riverton, UT 84065 Phone: 801-285-4600 | |
Rex A Outtrim, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3723 W 12600 S, Riverton, UT 84065 Phone: 801-285-4590 |